Loeb, Stacy http://orcid.org/0000-0003-3933-9207
Cheng, Heather H. http://orcid.org/0000-0002-1365-0702
Paller, Channing J. http://orcid.org/0000-0003-3658-1858
Weg, Emily
Johnson, Jennifer
Gross, Laura
Keith, Scott W.
Russo, Jessica
Hathaway, Feighanne
Rivera, Adrian
Giri, Veda N.
Funding for this research was provided by:
U.S. Department of Defense (080-27000-X17501, 080-27000-X17501, 080-27000-X17501, 080-27000-X17501)
Article History
Received: 14 July 2023
Revised: 10 November 2023
Accepted: 13 December 2023
First Online: 3 January 2024
Competing interests
: SL reports prior equity in Gilead, unrelated to this publication. HHC reports research funding to institution from Astellas, Clovis Oncology, Color Foundation, Janssen, Medivation, Promontory Therapeutics, Sanofi; Consultant to AstraZeneca; Royalties from UpToDate. CJP reports consulting for Bayer. FH reports educational consultant for AstraZeneca. The remaining authors report no relevant COI.